The Firm’s worldwide healthcare investment strategy involves investing, primarily through equity securities, in healthcare companies throughout the world, with an emphasis on the United States and other developed countries. The strategy employs modest leverage, is broadly diversified by geography and is designed to be 100% or more invested at any time.
